Kiniksa Pharmaceuticals International reported a gross margin of 90.32% and a net margin of 10.44% for the quarter ended Jun 2026. These financial ratios cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||
| Gross Margin | 77.12% | 79.37% | 86.89% | 81.35% | 93.00% | 89.16% | 85.45% | 89.23% | 86.45% | 88.51% | 86.75% | 88.66% | 82.08% | 85.40% | 87.03% | 88.14% | 88.80% | 89.64% | 90.29% | 90.32% | |||||||||||||
| EBT Margin | -253.51% | -233.66% | -72.34% | -71.43% | 47.14% | 146.90% | -19.37% | -1.73% | -12.68% | -86.37% | -17.88% | 2.12% | -6.42% | -13.86% | 11.30% | 14.59% | 15.02% | 11.51% | 15.25% | 12.79% | |||||||||||||
| EBIT Margin | -253.55% | -192.75% | -72.44% | -71.81% | 46.82% | 9.77% | -23.16% | -4.41% | -16.30% | 0.10% | -20.71% | -0.11% | -8.61% | -15.75% | 9.63% | 12.86% | 13.28% | 9.78% | 13.66% | 11.16% | |||||||||||||
| EBITDA Margin | -253.55% | -192.75% | -72.44% | -71.81% | 46.82% | 9.77% | -23.16% | -4.41% | -16.30% | 0.10% | -20.71% | -0.11% | -8.61% | -15.75% | 9.63% | 12.86% | 13.28% | 9.78% | 13.66% | 11.16% | |||||||||||||
| Operating Margin | -253.55% | -192.75% | -72.44% | -71.81% | 46.82% | 9.77% | -23.16% | -4.41% | -16.30% | 0.10% | -20.71% | -0.11% | -8.61% | -15.75% | 9.63% | 12.86% | 13.28% | 9.78% | 13.66% | 11.16% | |||||||||||||
| Net Margin | -252.53% | -235.15% | -78.32% | -74.08% | 226.05% | 143.05% | -25.38% | 20.95% | -20.66% | -59.05% | -22.17% | -3.60% | -11.31% | -7.25% | 6.20% | 11.37% | 10.19% | 7.02% | 10.54% | 10.44% | |||||||||||||
| FCF Margin | -242.16% | -112.61% | -105.91% | -28.40% | 62.60% | -19.13% | -2.07% | -5.36% | 25.33% | 6.87% | 0.78% | 1.22% | -2.00% | 13.26% | 17.69% | 17.87% | 18.54% | 24.98% | 23.35% | 19.10% | |||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 5.99M | 4.64M | 8.45M | 16.57M | 17.27M | 18.11M | 22.51M | 23.69M | 24.77M | 28.35M | 29.20M | 31.07M | 31.77M | 27.52M | 24.22M | 35.12M | 44.79M | 48.15M | 64.02M | 72.04M | |||||||||||||
| Assets AverageAssets Avg. | 266.03M | 242.83M | 231.88M | 220.77M | 335.26M | 459.81M | 451.27M | 463.60M | 483.70M | 504.69M | 523.00M | 531.05M | 548.86M | 567.93M | 589.94M | 630.24M | 686.74M | 737.98M | 794.46M | 860.70M | |||||||||||||
| Asset Utilization RatioAsset Util. | 0.31 | 0.41 | 0.53 | 0.48 | 0.52 | 0.61 | 0.51 | 0.54 | 0.58 | 0.64 | 0.70 | 0.75 | 0.82 | 0.84 | 0.87 | 0.92 | 0.95 | 0.98 | |||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -51.38 | -36.89 | -54.63 | -67.36 | 7.97 | 23.60 | -122.54 | 131.97 | -176.37 | -50.25 | -153.07 | -679.95 | -284.22 | -323.34 | 379.14 | 229.87 | 319.30 | 443.99 | 327.42 | 392.28 | |||||||||||||
| Price to SalesP/S | 129.75 | 86.75 | 42.78 | 49.90 | 18.01 | 33.76 | 31.10 | 27.65 | 36.45 | 29.67 | 33.94 | 24.46 | 32.15 | 23.45 | 23.50 | 26.14 | 32.55 | 31.19 | 34.52 | 40.95 | |||||||||||||
| Price to BookP/B | 7.33 | 8.79 | 8.28 | 8.77 | 4.65 | 5.27 | 3.85 | 4.80 | 6.03 | 5.64 | 6.27 | 6.11 | 8.26 | 6.55 | 7.08 | 8.28 | 10.99 | 11.11 | 12.21 | 15.25 | |||||||||||||
| Enterprise Value | 1,359.10M | 1,444.00M | 1,231.58M | 1,207.71M | 1,584.76M | 1,898.36M | 1,316.03M | 1,718.50M | 2,159.21M | 2,268.10M | 2,424.01M | 2,318.98M | 3,257.37M | 2,630.18M | 2,857.97M | 3,675.51M | 5,356.95M | 5,890.14M | 6,929.07M | 9,450.51M | |||||||||||||
| EV to EBIT | -44.32 | -39.97 | -52.81 | -62.36 | 34.14 | 313.93 | -117.54 | -544.86 | -197.60 | 0.03M | -146.54 | -0.02M | -337.27 | -136.29 | 215.34 | 182.32 | 223.01 | 297.96 | 236.75 | 347.52 | |||||||||||||
| EV to EBITDA | -44.32 | -39.97 | -52.81 | -62.36 | 34.14 | 313.93 | -117.54 | -544.86 | -197.60 | 0.03M | -146.54 | -0.02M | -337.27 | -136.29 | 215.34 | 182.32 | 223.01 | 297.96 | 236.75 | 347.52 | |||||||||||||
| Market Capitalization | 1,569.28M | 1,626.20M | 1,377.16M | 1,345.92M | 1,785.48M | 2,088.97M | 1,503.52M | 1,975.91M | 2,443.55M | 2,474.47M | 2,710.04M | 2,657.23M | 3,607.55M | 2,873.81M | 3,237.51M | 4,099.03M | 5,886.30M | 6,304.22M | 7,397.16M | 9,976.44M | |||||||||||||
| Price to FCFP/FCF | -53.58 | -77.04 | -40.40 | -175.68 | 28.77 | -176.42 | -0.00M | -515.50 | 143.86 | 431.77 | 0.00M | 0.00M | -0.00M | 176.89 | 132.85 | 146.29 | 175.53 | 124.85 | 147.83 | 214.40 | |||||||||||||
| EV to FCF | -46.40 | -68.41 | -36.13 | -157.64 | 25.54 | -160.32 | -0.00M | -448.34 | 127.12 | 395.76 | 0.00M | 0.00M | -0.00M | 161.90 | 117.28 | 131.17 | 159.75 | 116.65 | 138.48 | 203.10 | |||||||||||||
| EV to CFO | -47.67 | -76.47 | -33.43 | -154.36 | 25.54 | -163.99 | -308.42 | -459.12 | 127.12 | 524.42 | 607.98 | 448.72 | -0.00M | 140.13 | 128.02 | 130.85 | 159.07 | 109.29 | 138.03 | 200.24 | |||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -253.55% | -192.75% | -72.44% | -71.81% | 46.82% | 9.77% | -23.16% | -4.41% | -16.30% | 0.10% | -20.71% | -0.11% | -8.61% | -15.75% | 9.63% | 12.86% | 13.28% | 9.78% | 13.66% | 11.16% | |||||||||||||
| Return on Capital Employed [ROCE]ROCE | -74.87% | -79.11% | -71.98% | -61.78% | -11.62% | 2.37% | 5.28% | 9.16% | -4.47% | -5.71% | -6.66% | -6.16% | -5.79% | -9.76% | -3.21% | 0.87% | 6.78% | 12.90% | 14.61% | 14.54% | |||||||||||||
| Return on Assets [ROA]ROA | -68.04% | -68.22% | -60.98% | -54.27% | 40.21% | 58.16% | 62.13% | 68.02% | 16.00% | -11.97% | -12.59% | -15.95% | -15.22% | -7.61% | -2.87% | 0.76% | 5.23% | 8.00% | 9.20% | 9.37% |